uBiome
See the following -
Preventive Health Pioneer Dr. Michael McNamara Joins uBiome’s Advisory Board
uBiome, the leader in microbial genomics, welcomes Dr. Michael McNamara to its scientific advisory board. Dr. McNamara is the Medical Director at Dr. McNamara Premium Healthcare in Monaco, which specializes in preventive diagnostics using Magnetic Resonance Imaging and CT scanning along with blood analysis to produce a complete medical check-up. Dr. McNamara grew up in the U.S., undertaking his university and medical studies at the University of Michigan, followed by an internship in medicine and surgery in San Diego, California. He subsequently specialized in Radiology and Advanced Heart Scanning at UCSF...
- Login to post comments
uBiome Doubles Research Grant to Award Two Microbiome Researchers up to $100,000 Each
uBiome, the leading microbial genomics company, will double the number of academic researchers it will support after two projects tied for first place in a public vote to decide between six short-listed finalists. The two winning researchers, from the Yale School of Medicine and the University of Illinois at Chicago will therefore each receive up to $100,000 of uBiome microbiome testing kits and full laboratory analysis, fast-tracking studies of the vaginal microbiome of women with unexplained infertility, and the gut microbiome of athletes...
- Login to post comments
Are We Ready for Consumer Microbiome Testing?
Some people collect stamps. uBiome has a different area of interest. Since 2012, the San Francisco, California, startup has received and analyzed nearly 100,000 stool samples from customers trying to understand the unique population of microorganisms that call their body ‘home.’ It’s now preparing to scale-up and diversify its testing options, with the help a $15.5 million Series B funding round that was announced in early November. An alum of the Y Combinator, uBiome has grand plans. But is the microbiome science really there?...
- Login to post comments
ISOThrive and uBiome Partner on "Gut Health Challenge" Offering
ISOThrive today announced a partnership with uBiome, the leader in microbial genomics, to launch the "Gut Health Challenge." The ISOThrive Gut Health Challenge gives consumers the first-ever opportunity to feed their beneficial gut bacteria with necessary prebiotic soluble fiber and then scientifically measure and verify how this healthful daily practice affects and changes the organisms living in the gut...
- Login to post comments
Self-Experimenting Scientist Receives uBiome Grant to Investigate Consequences of Long-Term Antibiotic Use for Skin Conditions
uBiome, the leader in microbial genomics, has awarded a scientific grant to Dr. Eon Rios of Stanford University School of Medicine, supporting an investigation into how long-term use of oral antibiotics for skin conditions affects the gut microbiome. Microbial genomics leader uBiome, is awarding an ongoing series of in-kind scientific grants to ground-breaking microbiome studies. Its most recent microbiome impact grant award has been made to Dr. Eon Rios of Stanford University School of Medicine, who will study the effect of long-term use of oral antibiotics, prescribed for skin conditions, on the gut microbiome...
- Login to post comments
uBiome and University of Oxford Investigate the Relationship Between the Human Microbiome and Personality
Microbial genomics leader uBiome is partnering with the University of Oxford to run a pioneering investigation into the possible connections between adult personality and their gut microbiome. Past research on this subject has focused on mice, and this is the first study of its kind on humans. The study is open to adult participants in the UK, the US, as well as other countries. The experiment is led by Oxford University DPhil student Katerina Johnson, who works with leading evolutionary psychologist Professor Robin Dunbar (perhaps best known for establishing “Dunbar’s Number”—the cognitive limit to the number of individuals with whom any one person can maintain stable relationships) and respected neurobiologist Dr. Phil Burnet.
- Login to post comments
uBiome Awards Microbiome Impact Grant to Explore Effects of Heavy Drinking and Smoking on Oral Microbiome
Microbial genomics leader uBiome is awarding in-kind scientific grants to ground-breaking microbiome studies. A microbiome impact grant award has been made to Dr. Renato Polimanti of Yale University School of Medicine, who will study the effect of heavy smoking and drinking on the oral microbiome. Grant proposals have been vetted by the company’s scientific review committee. Dr. Polimanti is a genetic epidemiologist working in the Division of Human Genetics of the Department of Psychiatry at Yale University School of Medicine...
- Login to post comments
uBiome CEO Dr. Jessica Richman to Deliver Opening Keynote at American Medical Informatics Association Symposium
Jessica Richman, PhD, co-founder and CEO of the leading microbial genomics company, uBiome, will present the opening keynote address at the 2016 American Medical Informatics Association’s (AMIA) Annual Symposium, to be held in Chicago from November 12 - 16. The AMIA and its members aim to transform healthcare through trusted science, education, and practice in biomedical and health informatics. Jessica Richman, PhD, will join two other keynote speakers at the AMIA Symposium – Patricia Flatley Brennan, RN, PhD, Director of the NIH National Library of Medicine in Bethesda, Maryland and Eric Horvitz, MD, PhD, Technical Fellow and Director of the Microsoft Research Lab in Redmond...
- Login to post comments
uBiome Launches First Microbiome App Using ResearchKit; Initial focus is on Relationship Between Gut Bacteria and Weight Loss
iPhone users can now explore their gut bacteria, and also contribute to research about the relationship between the microbiome and human body weight with the launch of a ground-breaking app launched by the microbiome-testing company uBiome, which uses the ResearchKit framework designed by Apple. The app itself is free, and the first 1,000 users will also qualify for free microbiome testing, usually priced at $89.
- Login to post comments
uBiome Raises $22M, Announces New DNA-Sequencing Microbiome Screening Test
San Francisco-based uBiome, which makes a direct-to-consumer microbial genomic testing kit, has closed on a $22 million Series B funding round, led by 8VC with additional funding from Slow Ventures, Stanford’s StartX Fund and various angel investors. The funding will be used to deploy uBiome’s new testing kit, SmartGut, a sequencing-based clinical microbiome screening test. With an at-home collection kit, SmartGut aims to give individuals and their doctors access to a comprehensive screening test to weed out important microorganisms (which can only be detected through DNA sequencing) that could be causing health distress...
- Login to post comments
uBiome Reveals Details of Clinical Screening Test for Gut Health
Leading microbial genomics company uBiome has released a preprint of a publication submitted for peer review, entitled “16S rRNA Gene Sequencing as a Clinical Diagnostic Aid for Gastrointestinal-related Condition.” Details are available to the public in a preprint on the online archive BioRxiv. The pre-print comes alongside the announcement of the world’s first sequencing-based clinical microbiome test, SmartGut™. SmartGut™ enables physicians and patients to access a comprehensive microbiome screening test with a simple, at-home sample collection, to identify important commensal and pathogenic microorganisms...
- Login to post comments
UCSF Researcher to Investigate Diabetes and the Microbiome in Filipino Populations with uBiome Microbiome Impact Grant
Microbial genomics leader uBiome has awarded a Microbiome Impact Grant to Dr. Mark Seielstad of the University of California, San Francisco. Dr. Seielstad will investigate how patients’ risk of developing type 2 diabetes is affected by where they live. In partnership with the Philippine Genome Center, Dr. Seielstad will study the gut microbiome of Filipino type 2 diabetes patients in Manila and San Francisco, comparing them with an equivalent number of healthy control subjects in each city...
- Login to post comments